249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 249-OR
Author(s):  
EMANUELE BOSI ◽  
PAOLO POZZILLI ◽  
FRANCESCO GIORGINO ◽  
EFISIO COSSU ◽  
THOMAS LINN ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Adult Patients ◽  
Phase 2 ◽  
Double Blind ◽  
Onset Type ◽  
Phase 2 Trial ◽  
New Onset

scholarly journals Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot Randomized, Placebo-Controlled, Double-Blind Study: Response to Peters

Diabetes Care ◽  
2009 ◽  
Vol 32 (12) ◽  
pp. e154-e154 ◽  
Author(s):  
L. Mastrandrea ◽  
J. Yu ◽  
T. Behrens ◽  
J. Buchlis ◽  
C. Albini ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Etanercept Treatment ◽  
Onset Type ◽  
New Onset

scholarly journals Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial

2018 ◽  
Vol 20 (9) ◽  
pp. 2190-2199 ◽  
Author(s):  
Akira Shimada ◽  
Toshiaki Hanafusa ◽  
Atsutaka Yasui ◽  
Ganghyuck Lee ◽  
Yusuke Taneda ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Phase 2 ◽  
Double Blind ◽  
Phase 2 Trial

scholarly journals Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study

Diabetes Care ◽  
2009 ◽  
Vol 32 (7) ◽  
pp. 1244-1249 ◽  
Author(s):  
L. Mastrandrea ◽  
J. Yu ◽  
T. Behrens ◽  
J. Buchlis ◽  
C. Albini ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Etanercept Treatment ◽  
Onset Type ◽  
New Onset

Imatinib Therapy for Patients with Recent-Onset Type 1 Diabetes: A Randomised Blinded Phase 2 Trial

2021 ◽  
Author(s):  
Stephen E. Gitelman ◽  
Brian N. Bundy ◽  
Ele Ferrannini ◽  
Noha Lim ◽  
J. Lori Blanchfield ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Imatinib Therapy ◽  
Phase 2 ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial

scholarly journals Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

2013 ◽  
Vol 1 (4) ◽  
pp. 306-316 ◽  
Author(s):  
Stephen E Gitelman ◽  
Peter A Gottlieb ◽  
Mark R Rigby ◽  
Eric I Felner ◽  
Steven M Willi ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Antithymocyte Globulin ◽  
Phase 2 ◽  
Recent Onset ◽  
Onset Type ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document